A. Lorenzetti, Makiko Osato, Fang He, Cristiana Aperio, Antonio Ayala, S. Rasulova, M. Barbagallo
{"title":"Interim report from a 2-year double-blind rct testing fermented papaya preparation on immune enhancement, endothelial health and qol in elderly adults","authors":"A. Lorenzetti, Makiko Osato, Fang He, Cristiana Aperio, Antonio Ayala, S. Rasulova, M. Barbagallo","doi":"10.31989/ffhd.v13i2.1050","DOIUrl":null,"url":null,"abstract":"Background: Agingis associated with alterations in oxi-inflammatory-immune profile, and endothelial cell dysfunction. Indeed, increased generation of free radicals as well as immunosenescence are hallmarks of the aging process and age-related diseases. In the past 12 years or so, data has been accumulated on fermented papaya preparation (FPP®)(Osato Research Institute, Gifu, Japan), a specific functional food with robust redox and immune regulator nutrigenomics effect. The aim of this 2-year ongoing study of which we report the first-year data, was to test FPP® in redox, endothelial, and immune markers.Methods: Study population. From a total of 106 subjects, we report the analyzed data referring to 78 clinically stable, healthy, community-dwelling males and females, aged 60 to 75 years. The study was conducted using a double-blind method with designated groups A and B to fulfill the two different treatments. The two treatments are as follows: Group A, also known as “FPP Group,” was given one sachet two times per day containing 4.5g FPP®, along with one placebo capsule provided in the morning. Group B, also known as “AA Group,” was given one papaya-flavored sachet two times per day, along with one antioxidant mixture capsule in the morning. Morning blood samples were collected and tested for: Ultra-sensitive c-reactive protein (a highly sensitive ELISA), inducible nitric oxide synthase (iNOS) (by Human Nitric Oxide Synthase kit), asymmetric dimethylarginine, or ADMA, (a competitive enzyme-linked immunosorbent assay), apoptosis of PBMCs (by Annexin V staining) and MOS 36-item short-form health survey (SF-36) to assess quality of life. Screening and blood tests were carried out as follows: Visit I: Day 0 - Baseline, Visit II: Day 60, or 2 months, Visit III: 6 months, Visit IV: 11 months.Results: Plasma iNOS levels were comparable among both groups at the beginning of the study. FPP®-treated subjects showed a significant increased level at Visits II and III (P<0.05 vs baseline and vs AA). ADMA values were not affected by AA supplementation whereas FPP® treatment was associated with a significant decrease beginning with observation during Visit III (P<0.05 vs baseline and vs AA administration). The FPP® intervention was associated with improvements among several domains of quality of life such as physical function, general health, and mental components (P < 0.01 vs baseline and vs AA group). There was also at significant and comparable positive effect for time on vitality shown in both AA and FPP® groups.Conclusion: Unlike with the antioxidant treatment, the FPP® intervention yielded a transient decrease of ADMA, a decrease of iNOS and lower percentage in apoptotic PBMC. These results suggest that FPP®, by a more multifaceted, subcellular mechanism, as well as non-redox modulatory properties, was beneficially effective in regulating aging markers. These mechanisms are associated with a better SF-36 profile in support of FPP® as a candidate interventional functional food for health maintenance, and specifically in middle-age/elderly subjects.Keywords: Fermented Papaya Preparation, Nitric oxide, ADMA, apoptosis, antioxidants, SF-36","PeriodicalId":12623,"journal":{"name":"Functional Foods in Health and Disease","volume":" ","pages":""},"PeriodicalIF":1.3000,"publicationDate":"2023-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Functional Foods in Health and Disease","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31989/ffhd.v13i2.1050","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"FOOD SCIENCE & TECHNOLOGY","Score":null,"Total":0}
引用次数: 1
Abstract
Background: Agingis associated with alterations in oxi-inflammatory-immune profile, and endothelial cell dysfunction. Indeed, increased generation of free radicals as well as immunosenescence are hallmarks of the aging process and age-related diseases. In the past 12 years or so, data has been accumulated on fermented papaya preparation (FPP®)(Osato Research Institute, Gifu, Japan), a specific functional food with robust redox and immune regulator nutrigenomics effect. The aim of this 2-year ongoing study of which we report the first-year data, was to test FPP® in redox, endothelial, and immune markers.Methods: Study population. From a total of 106 subjects, we report the analyzed data referring to 78 clinically stable, healthy, community-dwelling males and females, aged 60 to 75 years. The study was conducted using a double-blind method with designated groups A and B to fulfill the two different treatments. The two treatments are as follows: Group A, also known as “FPP Group,” was given one sachet two times per day containing 4.5g FPP®, along with one placebo capsule provided in the morning. Group B, also known as “AA Group,” was given one papaya-flavored sachet two times per day, along with one antioxidant mixture capsule in the morning. Morning blood samples were collected and tested for: Ultra-sensitive c-reactive protein (a highly sensitive ELISA), inducible nitric oxide synthase (iNOS) (by Human Nitric Oxide Synthase kit), asymmetric dimethylarginine, or ADMA, (a competitive enzyme-linked immunosorbent assay), apoptosis of PBMCs (by Annexin V staining) and MOS 36-item short-form health survey (SF-36) to assess quality of life. Screening and blood tests were carried out as follows: Visit I: Day 0 - Baseline, Visit II: Day 60, or 2 months, Visit III: 6 months, Visit IV: 11 months.Results: Plasma iNOS levels were comparable among both groups at the beginning of the study. FPP®-treated subjects showed a significant increased level at Visits II and III (P<0.05 vs baseline and vs AA). ADMA values were not affected by AA supplementation whereas FPP® treatment was associated with a significant decrease beginning with observation during Visit III (P<0.05 vs baseline and vs AA administration). The FPP® intervention was associated with improvements among several domains of quality of life such as physical function, general health, and mental components (P < 0.01 vs baseline and vs AA group). There was also at significant and comparable positive effect for time on vitality shown in both AA and FPP® groups.Conclusion: Unlike with the antioxidant treatment, the FPP® intervention yielded a transient decrease of ADMA, a decrease of iNOS and lower percentage in apoptotic PBMC. These results suggest that FPP®, by a more multifaceted, subcellular mechanism, as well as non-redox modulatory properties, was beneficially effective in regulating aging markers. These mechanisms are associated with a better SF-36 profile in support of FPP® as a candidate interventional functional food for health maintenance, and specifically in middle-age/elderly subjects.Keywords: Fermented Papaya Preparation, Nitric oxide, ADMA, apoptosis, antioxidants, SF-36
背景:衰老与氧化-炎症-免疫谱的改变和内皮细胞功能障碍有关。事实上,自由基的增加和免疫衰老是衰老过程和年龄相关疾病的标志。在过去的12年左右的时间里,发酵木瓜制剂(FPP®)(Osato Research Institute, Gifu, Japan)作为一种具有强大的氧化还原和免疫调节营养基因组学效应的特定功能食品,已经积累了大量的数据。这项为期2年的研究的目的是测试FPP®在氧化还原、内皮和免疫标志物中的作用,我们报告了第一年的数据。方法:研究人群。从106名受试者中,我们报告了78名临床稳定、健康、社区居住的男性和女性的分析数据,年龄在60至75岁之间。本研究采用双盲方法进行,分为a组和B组,分别进行两种不同的治疗。两种治疗方法如下:A组,也被称为“FPP组”,每天两次,每次一袋,含4.5g FPP®,同时在早上提供一粒安慰剂胶囊。B组,也被称为“AA组”,每天两次给一个木瓜味的小袋,早上给一个抗氧化剂混合胶囊。采集晨血样本,检测:超敏感c反应蛋白(高敏感ELISA)、诱导型一氧化氮合酶(iNOS)(人一氧化氮合酶试剂盒)、不对称二甲基精氨酸或ADMA(竞争性酶联免疫吸附法)、PBMCs凋亡(Annexin V染色)和MOS 36项简短健康调查(SF-36),以评估生活质量。筛查和血液检查进行如下:第一次访问:第0天-基线,第二次访问:第60天,或2个月,第三次访问:6个月,第四次访问:11个月。结果:两组的血浆iNOS水平在研究开始时具有可比性。FPP®治疗的受试者在第II次和第III次就诊时水平显著升高(与基线和AA相比P<0.05)。补充AA不影响ADMA值,而FPP®治疗与第三次随访观察开始时显著降低相关(与基线和AA治疗相比P<0.05)。FPP®干预与生活质量的几个领域的改善有关,如身体功能、一般健康和精神成分(与基线组和AA组相比P < 0.01)。在AA和FPP®组中,时间对活力也有显著和可比的积极影响。结论:与抗氧化处理不同,FPP®干预可使ADMA、iNOS和PBMC细胞凋亡率短暂降低。这些结果表明,FPP®通过更多方面的亚细胞机制,以及非氧化还原调节特性,对调节衰老标志物有益有效。这些机制与更好的SF-36特征相关联,支持FPP®作为健康维持的候选干预性功能食品,特别是在中老年受试者中。关键词:发酵木瓜制剂,一氧化氮,ADMA,细胞凋亡,抗氧化剂,SF-36